@article{a5fe8dddc14840a99be898cfc30c5b23,
title = "Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series",
abstract = "In clinical studies, imiquimod 3.75% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or balding scalp. The aim of this study was to evaluate imiquimod 3.75% in a real-life clinical setting.",
keywords = "actinic keratosis, actinic keratosis",
author = "Sara Tambone and Fargnoli, {Maria C.} and Rodolfo Capizzi and Ketty Peris",
year = "2018",
doi = "10.23736/S0392-0488.17.05043-X",
language = "English",
volume = "153",
pages = "333--337",
journal = "Giornale Italiano di Dermatologia e Venereologia",
issn = "0392-0488",
publisher = "Edizioni Minerva Medica:Corso Bramante 83-85, 10126 Turin Italy:011 39 011 678282318, EMAIL:
[email protected], INTERNET: http://www.minervamedica.it, Fax: 011 39 011 674502",
}